All Outputs (2)

Use of procalcitonin as a biomarker for sepsis in moderate to major paediatric burns (2018)
Journal Article
Hollén, L., Hughes, R., Dodds, N., Coy, K., Marlow, K., Pullan, N., …Young, A. (2019). Use of procalcitonin as a biomarker for sepsis in moderate to major paediatric burns. Trauma, 21(3), 192-200. https://doi.org/10.1177/1460408618760940

Introduction: Accurate and early detection of sepsis poses a significant challenge in burn populations. Our objective was to assess whether procalcitonin is a marker of blood culture positive sepsis in moderate to severe paediatric burns. Methods: We... Read More about Use of procalcitonin as a biomarker for sepsis in moderate to major paediatric burns.

The Bristol Bladder trial: A single-arm phase II trial of cisplatin and cabazitaxel for muscle invasive transitional cell carcinoma of the urinary bladder prior to radical cystectomy (2018)
Journal Article
Bahl, A., Masson, S., Challapalli, A., Bravo, A., Pearson, S., Hilman, S., …Holly, J. (2018). The Bristol Bladder trial: A single-arm phase II trial of cisplatin and cabazitaxel for muscle invasive transitional cell carcinoma of the urinary bladder prior to radical cystectomy. Journal of Clinical Oncology, 36, 468-468. https://doi.org/10.1200/JCO.2018.36.6_suppl.468